tiprankstipranks
CSPC Pharmaceutical Group Limited (MX:1093N)
:1093N
Mexico Market
1093N
CSPC Pharmaceutical Group
RESEARCH TOOLSreports

CSPC Pharmaceutical Group (1093N) Ratios

0 Followers

CSPC Pharmaceutical Group Ratios

MX:1093N's free cash flow for Q2 2026 was HK$0.76. For the 2026 fiscal year, MX:1093N's free cash flow was decreased by HK$ and operating cash flow was HK$0.40. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.14 2.19 2.27 2.63 2.38
Quick Ratio
 1.93 1.88 1.95 2.32 2.13
Cash Ratio
 0.69 0.60 0.66 1.18 1.16
Solvency Ratio
 0.52 0.42 0.55 0.62 0.66
Operating Cash Flow Ratio
 0.19 0.58 0.44 0.41 0.92
Short-Term Operating Cash Flow Coverage
 10.49 17.94 10.86 9.28 53.11
Net Current Asset Value
HK$ 14.26B¥ 10.11B¥ 11.36B¥ 15.48B¥ 12.89B
Leverage Ratios
Debt-to-Assets Ratio
 0.01 0.01 0.01 0.01 0.02
Debt-to-Equity Ratio
 0.02 0.02 0.02 0.02 0.02
Debt-to-Capital Ratio
 0.02 0.02 0.02 0.02 0.02
Long-Term Debt-to-Capital Ratio
 <0.01 0.00 0.00 0.00 <0.01
Financial Leverage Ratio
 1.49 1.41 1.38 1.39 1.40
Debt Service Coverage Ratio
 29.15 11.83 13.57 15.27 37.63
Interest Coverage Ratio
 289.44 102.89 124.82 270.52 278.45
Debt to Market Cap
 <0.01 <0.01 <0.01 <0.01 <0.01
Interest Debt Per Share
 0.06 0.06 0.05 0.06 0.06
Net Debt to EBITDA
 -0.94 -1.04 -0.82 -1.32 -1.24
Profitability Margins
Gross Profit Margin
71.86%65.59%69.97%70.51%71.94%
EBIT Margin
27.95%15.27%19.69%23.75%24.64%
EBITDA Margin
32.36%20.69%24.30%27.29%28.02%
Operating Profit Margin
27.95%15.27%18.45%22.26%21.94%
Pretax Profit Margin
29.45%18.49%19.23%23.50%24.51%
Net Profit Margin
23.73%14.93%14.92%18.68%19.69%
Continuous Operations Profit Margin
24.80%14.91%14.96%19.31%20.14%
Net Income Per EBT
80.57%80.74%77.58%79.48%80.34%
EBT Per EBIT
105.38%121.08%104.21%105.55%111.71%
Return on Assets (ROA)
13.07%8.09%9.93%11.54%14.89%
Return on Equity (ROE)
20.68%11.39%13.67%16.09%20.89%
Return on Capital Employed (ROCE)
20.73%10.59%15.69%17.20%21.86%
Return on Invested Capital (ROIC)
17.35%8.43%12.05%15.69%17.78%
Return on Tangible Assets
13.87%8.65%10.57%12.12%15.70%
Earnings Yield
8.63%3.93%7.85%6.82%6.37%
Efficiency Ratios
Receivables Turnover
 3.64 2.65 3.16 2.90 4.20
Payables Turnover
 3.21 2.93 3.61 3.27 4.41
Inventory Turnover
 2.93 2.82 2.84 2.96 3.47
Fixed Asset Turnover
 2.26 1.88 2.26 2.70 2.68
Asset Turnover
 0.55 0.54 0.67 0.62 0.76
Working Capital Turnover Ratio
 2.17 2.08 2.05 2.07 2.11
Cash Conversion Cycle
 111.02 142.46 143.08 137.35 109.43
Days of Sales Outstanding
 100.21 137.63 115.33 125.67 87.00
Days of Inventory Outstanding
 124.48 129.49 128.74 123.46 105.21
Days of Payables Outstanding
 113.67 124.67 100.99 111.78 82.77
Operating Cycle
 224.69 267.12 244.07 249.13 192.20
Cash Flow Ratios
Operating Cash Flow Per Share
 0.24 0.52 0.36 0.35 0.77
Free Cash Flow Per Share
 0.18 0.35 0.15 0.19 0.56
CapEx Per Share
 0.07 0.17 0.21 0.16 0.22
Free Cash Flow to Operating Cash Flow
 0.72 0.68 0.41 0.55 0.72
Dividend Paid and CapEx Coverage Ratio
 0.86 1.36 0.73 0.85 1.96
Capital Expenditure Coverage Ratio
 3.60 3.09 1.69 2.21 3.54
Operating Cash Flow Coverage Ratio
 4.23 9.20 8.39 5.91 13.99
Operating Cash Flow to Sales Ratio
 0.09 0.23 0.14 0.13 0.29
Free Cash Flow Yield
2.35%4.14%3.11%2.65%6.78%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 11.45 25.55 12.73 14.67 15.71
Price-to-Sales (P/S) Ratio
 2.75 3.80 1.90 2.74 3.09
Price-to-Book (P/B) Ratio
 2.26 2.90 1.74 2.36 3.28
Price-to-Free Cash Flow (P/FCF) Ratio
 42.54 24.15 32.19 37.71 14.76
Price-to-Operating Cash Flow Ratio
 30.72 16.33 13.17 20.63 10.59
Price-to-Earnings Growth (PEG) Ratio
 0.12 -1.94 -0.53 -2.85 1.19
Price-to-Fair Value
 2.26 2.90 1.74 2.36 3.28
Enterprise Value Multiple
 7.57 17.33 7.00 8.72 9.80
Enterprise Value
 75.57B 90.85B 50.25B 74.88B 86.73B
EV to EBITDA
 7.57 17.33 7.00 8.72 9.80
EV to Sales
 2.45 3.59 1.70 2.38 2.75
EV to Free Cash Flow
 37.86 22.78 28.83 32.76 13.10
EV to Operating Cash Flow
 27.35 15.40 11.80 17.92 9.40
Tangible Book Value Per Share
 3.18 2.76 2.66 3.14 2.38
Shareholders’ Equity Per Share
 3.30 2.91 2.75 3.08 2.50
Tax and Other Ratios
Effective Tax Rate
 0.16 0.19 0.22 0.18 0.18
Revenue Per Share
 2.71 2.22 2.52 2.65 2.65
Net Income Per Share
 0.64 0.33 0.38 0.50 0.52
Tax Burden
 0.81 0.81 0.78 0.79 0.80
Interest Burden
 1.05 1.21 0.98 0.99 0.99
Research & Development to Revenue
 0.20 0.22 0.18 0.15 0.13
SG&A to Revenue
 0.24 0.29 0.34 0.00 0.00
Stock-Based Compensation to Revenue
 <0.01 >-0.01 <0.01 <0.01 <0.01
Income Quality
 0.37 1.56 0.98 0.57 1.30